[go: up one dir, main page]

SE0004229D0 - Inhalation of nitric oxide - Google Patents

Inhalation of nitric oxide

Info

Publication number
SE0004229D0
SE0004229D0 SE0004229A SE0004229A SE0004229D0 SE 0004229 D0 SE0004229 D0 SE 0004229D0 SE 0004229 A SE0004229 A SE 0004229A SE 0004229 A SE0004229 A SE 0004229A SE 0004229 D0 SE0004229 D0 SE 0004229D0
Authority
SE
Sweden
Prior art keywords
nitric oxide
treatment
combination
pulmonary vasoconstriction
airway constriction
Prior art date
Application number
SE0004229A
Other languages
English (en)
Swedish (sv)
Inventor
Goeran Hedenstierna
Luni Chen
Original Assignee
Aga Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aga Ab filed Critical Aga Ab
Priority to SE0004229A priority Critical patent/SE0004229D0/xx
Publication of SE0004229D0 publication Critical patent/SE0004229D0/xx
Priority to CNB018208940A priority patent/CN100443119C/zh
Priority to PCT/SE2001/002542 priority patent/WO2002040052A1/en
Priority to CA002429224A priority patent/CA2429224A1/en
Priority to AU2002214519A priority patent/AU2002214519B2/en
Priority to PL01362023A priority patent/PL362023A1/xx
Priority to EP01983064A priority patent/EP1339428B1/en
Priority to AT01983064T priority patent/ATE354375T1/de
Priority to ARP010105331A priority patent/AR031348A1/es
Priority to AU1451902A priority patent/AU1451902A/xx
Priority to US10/416,883 priority patent/US20040028753A1/en
Priority to DE60126814T priority patent/DE60126814T2/de
Priority to JP2002542424A priority patent/JP2004513928A/ja
Priority to ES01983064T priority patent/ES2282310T3/es
Priority to NZ526295A priority patent/NZ526295A/en
Priority to SK731-2003A priority patent/SK7312003A3/sk
Priority to IL15596801A priority patent/IL155968A0/xx
Priority to EEP200300226A priority patent/EE200300226A/xx
Priority to CZ20031617A priority patent/CZ20031617A3/cs
Priority to ZA200303845A priority patent/ZA200303845B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0004229A 2000-11-17 2000-11-17 Inhalation of nitric oxide SE0004229D0 (sv)

Priority Applications (20)

Application Number Priority Date Filing Date Title
SE0004229A SE0004229D0 (sv) 2000-11-17 2000-11-17 Inhalation of nitric oxide
CZ20031617A CZ20031617A3 (cs) 2000-11-17 2001-11-15 Inhalace oxidu dusnatého
ARP010105331A AR031348A1 (es) 2000-11-17 2001-11-15 Inhalacion de oxido nitrico
US10/416,883 US20040028753A1 (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide
CA002429224A CA2429224A1 (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide
AU2002214519A AU2002214519B2 (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide
PL01362023A PL362023A1 (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide
EP01983064A EP1339428B1 (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide
AT01983064T ATE354375T1 (de) 2000-11-17 2001-11-15 Inhalation von stickoxid
CNB018208940A CN100443119C (zh) 2000-11-17 2001-11-15 一氧化氮的吸入
AU1451902A AU1451902A (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide
PCT/SE2001/002542 WO2002040052A1 (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide
DE60126814T DE60126814T2 (de) 2000-11-17 2001-11-15 Inhalation von stickoxid
JP2002542424A JP2004513928A (ja) 2000-11-17 2001-11-15 一酸化窒素の吸入
ES01983064T ES2282310T3 (es) 2000-11-17 2001-11-15 Inhalacion de oxido nitrico.
NZ526295A NZ526295A (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide
SK731-2003A SK7312003A3 (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide
IL15596801A IL155968A0 (en) 2000-11-17 2001-11-15 Inhalation of nitric oxide
EEP200300226A EE200300226A (et) 2000-11-17 2001-11-15 Lämmastikoksiidi inhaleerimine
ZA200303845A ZA200303845B (en) 2000-11-17 2003-05-19 Inhalation of nitric oxide.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0004229A SE0004229D0 (sv) 2000-11-17 2000-11-17 Inhalation of nitric oxide

Publications (1)

Publication Number Publication Date
SE0004229D0 true SE0004229D0 (sv) 2000-11-17

Family

ID=20281873

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0004229A SE0004229D0 (sv) 2000-11-17 2000-11-17 Inhalation of nitric oxide

Country Status (19)

Country Link
US (1) US20040028753A1 (xx)
EP (1) EP1339428B1 (xx)
JP (1) JP2004513928A (xx)
CN (1) CN100443119C (xx)
AR (1) AR031348A1 (xx)
AT (1) ATE354375T1 (xx)
AU (2) AU1451902A (xx)
CA (1) CA2429224A1 (xx)
CZ (1) CZ20031617A3 (xx)
DE (1) DE60126814T2 (xx)
EE (1) EE200300226A (xx)
ES (1) ES2282310T3 (xx)
IL (1) IL155968A0 (xx)
NZ (1) NZ526295A (xx)
PL (1) PL362023A1 (xx)
SE (1) SE0004229D0 (xx)
SK (1) SK7312003A3 (xx)
WO (1) WO2002040052A1 (xx)
ZA (1) ZA200303845B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756047B2 (en) * 2000-05-12 2004-06-29 The University Of Toledo Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
US6750238B1 (en) 2000-05-12 2004-06-15 The University Of Toledo Aralkyl ester soft drugs
US7049326B2 (en) 2000-05-12 2006-05-23 The University Of Toledo Method and compositions for temporarily incapacitating subjects
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor
EP1400243A1 (en) * 2002-09-19 2004-03-24 Tanabe Seiyaku Co., Ltd. Calcium-activated K channel activator
US8518457B2 (en) * 2004-05-11 2013-08-27 Pulmonox Technologies Corporation Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
DK176782B1 (da) * 2006-08-04 2009-08-17 Innovision As Fremgangsmåde til at kompensere for effekten af recirkulation af blodoplöselig gas på bestemmelse af pulmonal blodgennemströmning i gentagne tests med genånding af inert gas
ES2768250T5 (es) 2011-10-03 2023-12-21 Nitricgen Inc Aparato y método para generar óxido nítrico en cantidades controladas y precisas
EP3421042B1 (en) * 2012-03-07 2024-04-17 Beyond Air Ltd Inhalation of nitric oxide for treating respiratory diseases
JP6689188B2 (ja) 2013-03-15 2020-04-28 ザ ジェネラル ホスピタル コーポレイション 一酸化窒素の吸気合成
CA2906660C (en) 2013-03-15 2021-05-25 The General Hospital Corporation Synthesis of nitric oxide gas for inhalation
EP3753597B1 (en) 2014-10-20 2025-06-25 The General Hospital Corporation Systems and methods for synthesis of nitric oxide
KR20190005839A (ko) 2016-03-25 2019-01-16 더 제너럴 하스피탈 코포레이션 산화질소의 전기 플라즈마 합성을 위한 전달 시스템 및 방법
BR112019016708B1 (pt) 2017-02-27 2024-01-30 Third Pole, Inc Sistemas de geração de óxido nítrico
EP4095094A1 (en) 2017-02-27 2022-11-30 Third Pole, Inc. Systems and methods for ambulatory generation of nitric oxide
MX2020010523A (es) 2017-02-27 2021-02-09 Third Pole Inc Sistemas y metodos para generar oxido nitrico.
BR112019020317A2 (pt) 2017-03-31 2020-04-28 Massachusetts Gen Hospital sistemas e métodos para um gerador de óxido nítrico resfriado
WO2020232419A1 (en) 2019-05-15 2020-11-19 Third Pole, Inc. Systems and methods for generating nitric oxide
CN114269685A (zh) 2019-05-15 2022-04-01 第三极股份有限公司 用于一氧化氮生成的电极
WO2021142472A1 (en) 2020-01-11 2021-07-15 Third Pole, Inc. Systems and methods for nitric oxide generation with humidity control
EP4167920A4 (en) 2020-06-18 2024-06-12 Third Pole, Inc. Systems and methods for preventing and treating infections with nitric oxide
US20220362239A1 (en) * 2021-05-11 2022-11-17 Pharmazz, Inc. Pharmaceutical composition and method for treatment of acute respiratory distress syndrome (ards) in coronavirus disease (covid-19)
JP2024534608A (ja) 2021-09-23 2024-09-20 サード ポール，インコーポレイテッド 一酸化窒素を送達するシステム及び方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536515A (en) * 1982-12-06 1985-08-20 Merck Frosst Canada, Inc. Substituted phenylalkenoic acids and esters
US4537906A (en) * 1982-12-06 1985-08-27 Merck Frosst Canada, Inc. Substituted phenylalkenoic acids and esters
DE122007000103I1 (de) * 1990-12-05 2008-04-03 Gen Hospital Corp Verwendung von NO zur Behandlung der persistenten pulmonalen Hypertonie des Neugeborenen
JP2003523958A (ja) * 1999-12-23 2003-08-12 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−２の阻害剤、組成物ならびに使用法

Also Published As

Publication number Publication date
SK7312003A3 (en) 2004-02-03
CZ20031617A3 (cs) 2004-02-18
DE60126814T2 (de) 2007-10-25
ATE354375T1 (de) 2007-03-15
IL155968A0 (en) 2003-12-23
ES2282310T3 (es) 2007-10-16
EP1339428B1 (en) 2007-02-21
EE200300226A (et) 2003-08-15
WO2002040052A1 (en) 2002-05-23
DE60126814D1 (de) 2007-04-05
CN100443119C (zh) 2008-12-17
CN1481256A (zh) 2004-03-10
EP1339428A1 (en) 2003-09-03
US20040028753A1 (en) 2004-02-12
AR031348A1 (es) 2003-09-17
PL362023A1 (en) 2004-10-18
AU1451902A (en) 2002-05-27
CA2429224A1 (en) 2002-05-23
ZA200303845B (en) 2004-09-09
NZ526295A (en) 2004-10-29
AU2002214519B2 (en) 2004-08-12
JP2004513928A (ja) 2004-05-13

Similar Documents

Publication Publication Date Title
SE0004229D0 (sv) Inhalation of nitric oxide
WO2001093846A3 (en) Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of clycosaminoglycans
CA2146954A1 (en) Breath activated nicotine inhalers
DK1174138T3 (da) Anvendelse af mometasonfuroat til behandling af luftvejs- og lungesygdomme
MXPA05010402A (es) Oxido nitrico en el tratamiento de la inflamacion.
ATE347361T1 (de) Kombination eines pde4-inhibitors mit tiotropium zur behandlung obstruktiver atemwegserkrankungen
NO20030337L (no) Anvendelse av hydroksyetylrutosider i fremstilling av medikamenter til behandling av vanlig forkjolelse, virus- og/eller bakterieinfeksjon i luftveiene og/eller oyne, rhinitt og hoyfeber
TR200001891T2 (tr) ASPB28- İnsan ensülini ve kullanımı.
RU2004105865A (ru) Новый способ лечения
WO2007109118A3 (en) RECOMBINANT HUMAN CC 10 (rhCC10) FOR TREATMENT OF RESPIRATORY DISORDERS
Groeben et al. Combined intravenous lidocaine and inhaled salbutamol protect against bronchial hyperreactivity more effectively than lidocaine or salbutamol alone
ATE418994T1 (de) Argon enthaltendes arzneimittel zum inhalieren und dessen verwendung zur behandlung von neurotoxizität
PT1261333E (pt) Utilizacao de topiramato para o tratamento e diagnostico de transtorno do sono relacionado com a respiracao e meios para realizar o metodo e o diagnostico
MXPA03011702A (es) Composicion que comprende un inhibidor de fosodiesterasa 4 y un antagonista de receptor h1 y el uso de los mismos para la elaboracion de un medicamento para el tratamiento de enfermedades respiratorias.
Agarwal et al. Evaluation of capsaicin ointment at the Korean hand acupressure point K‐D2 for prevention of postoperative nausea and vomiting
Park et al. Prevention of postoperative sore throat using capsicum plaster applied at the Korean hand acupuncture point
NO20073909L (no) Forstover-formulering
SE9903985D0 (sv) Use of nitric oxide
Mujtaba et al. Digital ischemia from accidental epinephrine injection
Selcow Ancillary Medical Therapy: Help or Hindrance
Anderson et al. C106 MONEY DON'T MATTER TONIGHT: PULMONARY HYPERTENSION ASSESSMENT, PROGNOSTICATION, AND TREATMENT: Tapit Treatment Of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil: An Open Label, Pilot Study
MD2491F1 (en) Use of bromide of S-ethyl isothiouronium (isoturone) for algodysmenorrhea treatment
Aït-Khaled et al. Treating the patient with asthma [Educational Series: Asthma. Serialised guide. Management of asthma: the essentials of good clinical practice. Number 3 in the series]
Wynne et al. Ambulatory care and rehabilitation in copd
Butler Non-surgical alternatives to continous positive airway pressure